Literature DB >> 11220100

[Radiofrequency ablation of liver metastases. Technique and initial results].

T Helmberger1, N Holzknecht, U Schöpf, C Kulinna, H Rau, A Stäbler, M Reiser.   

Abstract

Primary and secondary malignant hepatic tumors are the most common tumors with a much more higher incidence of hepatic metastases. Chemotherapy and radiation therapy are in general ineffective. Therefore, surgical resection is considered the method of choice in the treatment of malignant hepatic lesions. Due to systemic disease, general medical or procedure-related reasons hindering surgery, only 25 to 45% of the patients with metastatic disease of the liver are suitable for a curative surgical therapy. In resectable lesions thermoablative methods can offer an alternative to the surgical therapy. The most experience exists in radiofrequency ablation techniques. Technique, indications, contraindications, and limitations of the radiofrequency ablation will be discussed together with a presentation of own cases and a review of the literature. In 37 patients the primary technical success rate of the ablation was 97.3% (72 of 74 lesions). In 4 cases a hematoma of the liver capsule occurred. One of these had to be treated interventionally. During the limited follow-up period of 9 months no local recurrency was seen, however 4 patients developed new hepatic metastases. Beside differences in practicability it is not yet clarified if there are differences in the therapeutic efficacy of the different thermoablation methods. Nevertheless, the results of the ablation therapy may parallel the results of the surgical resection. Interstitial thermotherapy can provide a valuable contribution to local tumor control. However, the final significance of the thermoablation techniques within oncological therapy regimens has to be evaluated in further multidisciplinary studies.

Entities:  

Mesh:

Year:  2001        PMID: 11220100     DOI: 10.1007/s001170050929

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  11 in total

1.  [MRI-assisted thermometry for regional hyperthermia and interstitial laser thermotherapy].

Authors:  M Peller; A Muacevic; H Reinl; R Sroka; S Abdel-Rahman; R Issels; M F Reiser
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

Review 2.  [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; F Streitparth; G Wieners; E Lopez-Häninnen
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

3.  [Stereotactic radiation therapy for liver metastases].

Authors:  K K Herfarth; J Debus
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

4.  Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.

Authors:  Bertrand Janne d'Othée; Constantinos T Sofocleous; Nader Hanna; Robert J Lewandowski; Michael C Soulen; Jean-Nicolas Vauthey; Steven J Cohen; Alan P Venook; Matthew S Johnson; Andrew S Kennedy; Ravi Murthy; Jean-Francois Geschwind; Stephen T Kee
Journal:  J Vasc Interv Radiol       Date:  2012-02       Impact factor: 3.464

5.  [Present state of radio frequency ablation of liver tumors in Germany].

Authors:  M Birth; P Hildebrand; G Dahmen; A Ziegler; D C Bröring; C Hillert; H P Bruch
Journal:  Chirurg       Date:  2004-04       Impact factor: 0.955

Review 6.  [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature].

Authors:  K Wasser; F Giebel; R Fischbach; H Tesch; P Landwehr
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

Review 7.  [Percutaneous radiofrequency ablation of liver cell carcinoma: a current overview].

Authors:  J Kettenbach; M Blum; E Kilanowicz; S M Schwaighofer; J Lammer
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

8.  [Current concepts and recent developments of laser ablation in tumor therapy].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; R Puls; N Hosten; U Speck; J Ricke; H Oettle; P Hohenberger; R Felix
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

Review 9.  [Radiofrequency ablation of liver metastases].

Authors:  P L Pereira; S Clasen; A Boss; D Schmidt; C Gouttefangeas; C Burkart; J Wiskirchen; G Tepe; C D Claussen
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

10.  Quality improvement guidelines for radiofrequency ablation of liver tumours.

Authors:  Laura Crocetti; Thierry de Baere; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2010-02       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.